 |
PositiveID Corporation Obtains Certification From AT&T for iglucose Mobile Health System for Individuals With Diabetes
Jan 30, 2012
|
25.6 KB |
| |
DELRAY BEACH, Fla., Jan. 30, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it has obtained certification from AT&T for PositiveID's iglucose™ mobile health system, designed to simplify diabetes management for the millions of individuals...
|
|
PositiveID Corporation and IDEAL LIFE Partner to Bring iglucose to Market for Wireless Diabetes Management
Jan 9, 2012
|
22.8 KB |
| |
DELRAY BEACH, Fla. and TORONTO, Jan. 9, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it will work in partnership with IDEAL LIFE, Inc. ("IDEAL LIFE"), the remote health management leader, to bring iglucose™ to market. IDEAL LIFE, found...
|
|
PositiveID Corporation to Launch Clinical Trial of Its Easy Check Non-Invasive Breath Glucose Detection Device This Month
Jan 5, 2012
|
22.7 KB |
| |
DELRAY BEACH, Fla., Jan. 5, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, announced today it will launch the first clinical trial of its Easy Check™ non-invasive breath glucose detection device for people with diabetes later this month. Th...
|
|
PositiveID Corporation Partners With Diabetes Research Institute at the University of Miami and Schneider Children's Medical Center of Israel to Support Development of PositiveID's Diabetes Management Products
Jan 3, 2012
|
20.9 KB |
| |
Diabetes Research Institute is a Recognized World Leader in Cure-Focused Diabetes Research
Schneider Children's Medical Center of Israel is the Only Highly Specialized Care Hospital of Its Kind in Israel and the Middle East
DELRAY BEACH, Fla., Jan. 3, 2012 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Com...
|
|
PositiveID Corporation Enters into a Letter of Intent to Sell Non-Core Assets
Dec 19, 2011
|
17.5 KB |
| |
DELRAY BEACH, Fla., Dec. 19, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and molecular diagnostic systems, announced today it has entered into a non-binding Letter of Intent to sell non-core assets including the Company's VeriChip and Health Li...
|
|
PositiveID Corporation Announces 2011 Accomplishments and Discusses Outlook for 2012
Dec 12, 2011
|
22.5 KB |
| |
Company Receives FDA Clearance for Its iglucose System, Completes Easy Check Prototype and
Initial Testing, Completes Development of Glucose Sensor for GlucoChip, and Acquires
MicroFluidic Systems
Company Expects to Generate Revenue in 2012 Through Commercialization of iglucose and
Contract Awards for Its MicroFluidic Systems...
|
|
PositiveID Corporation Appoints William J. Caragol, the Company's CEO, Chairman of Its Board of Directors
Dec 7, 2011
|
16.2 KB |
| |
DELRAY BEACH, Fla., Dec. 7, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB: PSID), a developer of medical technologies and molecular diagnostic systems, announced today that its Board of Directors (the "Board") has appointed William J. Caragol its Chairman. Caragol has been CEO since August 2011, President since ...
|
|
U.S. Patent and Trademark Office Grants Patent to PositiveID Corporation for Portable Pathogen Detection
Dec 6, 2011
|
21.2 KB |
| |
DELRAY BEACH, Fla., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies and molecular diagnostic systems, announced today the U.S. Patent and Trademark Office has granted the Company Patent No. 8,053,214, "Apparatus and Method for Extracting and Analyzing an Analyte f...
|
|
PositiveID Corporation Successfully Passes FCC Requirements to Sell Its iglucose System for Diabetes Management in the U.S.
Nov 28, 2011
|
22.5 KB |
| |
DELRAY BEACH, Fla., Nov. 28, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today its iglucose™ mobile health device has successfully completed all Federal Communications Commission ("FCC") required testin...
|
|
U.S Food and Drug Administration Clears PositiveID's iglucose System for Diabetes Management
Nov 16, 2011
|
21.8 KB |
| |
iglucose is a First-of-its-Kind Wireless Communication System for Diabetes Management
PositiveID to Begin Commercialization Efforts in First Quarter 2012
DELRAY BEACH, Fla., Nov. 16, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management a...
|
|
PositiveID Corporation Announces Third Quarter 2011 Highlights
Nov 15, 2011
|
23.3 KB |
| |
DELRAY BEACH, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today its third quarter 2011 operational highlights, including FDA submission of its iglucose™ 510(k) appli...
|
|
PositiveID Corporation and Development Partner RECEPTORS LLC to Present Their Invention of a Sensing System for an Implantable Glucose Sensor at 11th Annual Diabetes Technology Meeting
Oct 26, 2011
|
18.7 KB |
| |
DELRAY BEACH, Fla., Oct. 26, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today that its development partner RECEPTORS LLC ("Receptors") will present at the 11th Annual Diabetes Technology Meeting to be held O...
|
|
U.S. Department of Homeland Security Directs and Funds Development of PositiveID Corporation's Ricin Detection Assay to Protect Nation Against Biological Threats
Oct 18, 2011
|
19.4 KB |
| |
Company Launches Detection Assay With New White Paper on Its Ricin Assay at www.positiveidcorp.com
DELRAY BEACH, Fla., Oct. 18, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced that ...
|
|
Sanofi and the American Medical Directors Association Foundation Sponsor Study Using PositiveID Corporation's iglucose Mobile Health System for Diabetes Management
Oct 4, 2011
|
18.4 KB |
| |
DELRAY BEACH, Fla., Oct. 4, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today that its iglucose™ mobile health system to facilitate diabetes management will be used in a diabetes study sponsored by the ...
|
|
Diabetes Educators Confirm PositiveID Corporation's iglucose Would Improve Patient Outcomes
Sep 27, 2011
|
17.0 KB |
| |
Eighty-Three Percent of Diabetes Educators Polled at the American Association of Diabetes Educators Conference Believe iglucose Would Improve Patient Outcomes
PositiveID Submitted Its 510(k) Pre-Market Notification Application for iglucose to FDA in July 2011
DELRAY BEACH, Fla., Sept. 27, 2011 (GLOBE NEWSWIRE) -- PositiveID Corpora...
|
|
PositiveID Corporation Appoints Yuval Rabin to Its Advisory Board
Sep 21, 2011
|
16.5 KB |
| |
DELRAY BEACH, Fla., Sept. 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it has appointed Yuval Rabin to its advisory board. Rabin is Managing Partner at Oris Investments and...
|
|
PositiveID Corporation Expands Its Biological Detection Capabilities to Address Avian Flu and Other Pandemic Viruses
Sep 14, 2011
|
18.8 KB |
| |
DELRAY BEACH, Fla., Sept. 14, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that it is expanding its biological detection capabilities to include the detection of H5N1, or avian ...
|
|
PositiveID Corporation's iglucose Mobile Health System for Diabetes Management Selected to be Featured at Rogers Wireless Technology Showcase 2011
Sep 8, 2011
|
20.6 KB |
| |
DELRAY BEACH, Fla., Sept. 8, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that Rogers Communications has chosen to feature PositiveID's iglucose™ mobile health system for ...
|
|
PositiveID Corporation to Present at International Security and Defense Conference
Sep 6, 2011
|
17.9 KB |
| |
DELRAY BEACH, Fla., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, announced today that M. Allen Northrup, Ph.D., CEO of the Company's MicroFluidic Systems ("MFS") subsidiary, will present a...
|
|
REMINDER: PositiveID Corporation to Host Investor Call and Webcast on September 7 at 10:00 am ET
Sep 6, 2011
|
17.5 KB |
| |
DELRAY BEACH, Fla., Sept. 6, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management, clinical diagnostics and bio-threat detection, will host a conference call and webcast for investors, media and other interested parties on Wednesday, September 7, 2011 a...
|
|
|